abstract |
A pharmaceutical dosage form comprising a solid dispersion product comprising a pharmaceutically active ingredient, at least one pharmaceutically acceptable polymer, and at least one pharmaceutically acceptable solubilizer, said pharmaceutically active ingredient being N- (4- (4 - ((2 - (4- chlorophenyl) -5,5-dimethyl-1-cyclohex-1-en-1-yl) methyl) piperazin-1-yl) benzoyl) -4 - (((1R) -3- (morpholin-4 -il) -1- ((phenylsulfanyl) methyl) propyl) amino) -3 - ((trifluoromethyl) sulfonyl) benzenesulfonamide, a salt, hydrate or solvate thereof. |